Pressure is building across the private system, as a new survey highlights billing constraints, ethical tensions in emergencies, and growing frustration with insurers.
Australia’s anaesthetists are warning that rising patient out-of-pocket costs are being driven less by specialist fees and more by mounting system pressures, including stagnant rebates and insurer settings that have failed to keep pace with the cost of care.
A new survey of more than 1100 anaesthetists by the Australian Society of Anaesthetists paints a picture of a specialty operating within tight structural constraints, where fees are shaped as much by external factors as by clinical work.
The findings suggest anaesthetists are attempting to balance procedural complexity, insurer rules and patient affordability, while absorbing increasing financial pressure themselves.
Anaesthetist fees are primarily determined by the duration and complexity of procedures, alongside private health insurer “gap” arrangements and benchmark pricing frameworks, according to the survey.
But a consistent gap remains between what anaesthetists currently charge and what they believe reflects the true cost of care, with respondents reporting their preferred rates exceed current levels nationally.
At the same time, participation in insurer gap schemes is widespread, with around 84% of anaesthetists using “no gap” or “known gap” arrangements, often accepting lower payments to limit patient costs and avoid billing complexity.
The results reinforce a broader trend identified in national policy research that out-of-pocket costs are rising across the system. Analyses by the Grattan Institute and others – such as former secretary of the federal department of health Brendan Murphy’s policy piece in the Medical Journal of Australia– have shown that two-thirds of specialist consultations now involve a gap fee, with costs increasing significantly over the past decade.
However, comparative data suggests anaesthetists are not among the highest-charging specialties. Research drawing on Medicare data has consistently found that fields such as psychiatry and dermatology attract substantially higher out-of-pocket costs for patients, with wide variation in fees across specialties.
That reflects a key structural difference: unlike many other specialists, anaesthetists typically operate within hospital-based episodes of care, where billing is more tightly linked to procedures and insurer arrangements. That “hospital-constrained” environment tends to limit extreme fee variation, even as gaps persist.
The ASA survey suggests these constraints are translating into practical and ethical challenges, particularly around informed financial consent.
While consent processes are well established for planned procedures – typically provided by patients in writing ahead of time – that breaks down in emergency and unplanned care.
In urgent situations, anaesthetists report relying on verbal consent at the point of care, often with limited opportunity to discuss fees in detail.
Many say they default to no-gap or known-gap billing in these cases, not as a commercial decision but to avoid placing additional stress on patients during vulnerable moments.
Free-text responses in the survey highlight widespread discomfort with discussing fees immediately before procedures, with some clinicians raising ethical concerns about whether meaningful consent is possible in emergency settings.
Others report routinely waiving or reducing fees in such circumstances, reflecting what the survey describes as a “regular feature” of anaesthesia practice rather than an exception.
This aligns with broader system findings that financial discussions in healthcare are often constrained by timing and patient vulnerability, particularly in acute care settings.
Beyond consent issues, the survey also points to ongoing tension between anaesthetists and private health insurers, a long-standing and ongoing theme in the sector.
Related
Respondents consistently cite a lack of indexation in both Medicare and private health insurance rebates as a key driver of rising gaps, arguing that fixed rebate structures have not kept pace with inflation or increasing practice costs.
Insurer rules, including caps on gap payments and rebate reductions when fees exceed set limits, are also seen as shifting costs to patients while leaving clinicians to manage the consequences.
Some survey respondents describe these arrangements as distorting pricing and creating a perception that doctors are responsible for out-of-pocket costs, when in reality fees are shaped by broader funding settings.
For anaesthetists, the survey indicates their position within the private health system is relatively constrained compared to other fields, with less scope for fee variation but continued exposure to the consequences of under-indexed rebates.
Respondents identified higher Medicare and insurer rebates, along with improved indexation, as the most effective measures to reduce patient out-of-pocket costs.
Transparency initiatives and fee regulation were viewed as secondary to addressing what clinicians see as the underlying funding gap.
